DE4025879A1 - Neue adenosin derivate, deren herstellung und verwendung - Google Patents

Neue adenosin derivate, deren herstellung und verwendung

Info

Publication number
DE4025879A1
DE4025879A1 DE4025879A DE4025879A DE4025879A1 DE 4025879 A1 DE4025879 A1 DE 4025879A1 DE 4025879 A DE4025879 A DE 4025879A DE 4025879 A DE4025879 A DE 4025879A DE 4025879 A1 DE4025879 A1 DE 4025879A1
Authority
DE
Germany
Prior art keywords
carbonate
ethylamide
purinyl
deoxy
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE4025879A
Other languages
German (de)
English (en)
Inventor
Fulvio Dr Gadient
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Sandoz Patent GmbH
Original Assignee
Sandoz AG
Sandoz Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG, Sandoz Patent GmbH filed Critical Sandoz AG
Priority to DE4025879A priority Critical patent/DE4025879A1/de
Priority to AU83032/91A priority patent/AU638600B2/en
Priority to CA002064869A priority patent/CA2064869A1/en
Priority to JP3513113A priority patent/JPH05502889A/ja
Priority to PCT/CH1991/000170 priority patent/WO1992003463A1/de
Priority to PL29436891A priority patent/PL294368A1/xx
Priority to FI921691A priority patent/FI921691A0/fi
Priority to EP91913964A priority patent/EP0496852A1/de
Priority to HU921080A priority patent/HUT60504A/hu
Priority to TW080109279A priority patent/TW197448B/zh
Publication of DE4025879A1 publication Critical patent/DE4025879A1/de
Priority to CS92978A priority patent/CS97892A3/cs
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE4025879A 1990-08-16 1990-08-16 Neue adenosin derivate, deren herstellung und verwendung Withdrawn DE4025879A1 (de)

Priority Applications (11)

Application Number Priority Date Filing Date Title
DE4025879A DE4025879A1 (de) 1990-08-16 1990-08-16 Neue adenosin derivate, deren herstellung und verwendung
PL29436891A PL294368A1 (en) 1990-08-16 1991-08-13 Method of obtaining adenosine 2', 3'-carbonates
CA002064869A CA2064869A1 (en) 1990-08-16 1991-08-13 Adenosine derivatives, their production and use
JP3513113A JPH05502889A (ja) 1990-08-16 1991-08-13 新規アデノシン誘導体、その製造および使用法
PCT/CH1991/000170 WO1992003463A1 (de) 1990-08-16 1991-08-13 Neue adenosin-derivate, deren herstellung und verwendung
AU83032/91A AU638600B2 (en) 1990-08-16 1991-08-13 Novel adenosine derivatives, their production and use
FI921691A FI921691A0 (fi) 1990-08-16 1991-08-13 Nya adenosinderivat, deras framstaellning och anvaendning.
EP91913964A EP0496852A1 (de) 1990-08-16 1991-08-13 Neue adenosin-derivate, deren herstellung und verwendung
HU921080A HUT60504A (en) 1990-08-16 1991-08-13 Process for producing new adenosine derivatives and pharmaceutical compositions comprising such compounds
TW080109279A TW197448B (enExample) 1990-08-16 1991-11-26
CS92978A CS97892A3 (en) 1990-08-16 1992-04-01 Adenosine derivatives, process of their preparation and therapeuticalcompositions comprising said derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4025879A DE4025879A1 (de) 1990-08-16 1990-08-16 Neue adenosin derivate, deren herstellung und verwendung

Publications (1)

Publication Number Publication Date
DE4025879A1 true DE4025879A1 (de) 1992-02-20

Family

ID=6412310

Family Applications (1)

Application Number Title Priority Date Filing Date
DE4025879A Withdrawn DE4025879A1 (de) 1990-08-16 1990-08-16 Neue adenosin derivate, deren herstellung und verwendung

Country Status (11)

Country Link
EP (1) EP0496852A1 (enExample)
JP (1) JPH05502889A (enExample)
AU (1) AU638600B2 (enExample)
CA (1) CA2064869A1 (enExample)
CS (1) CS97892A3 (enExample)
DE (1) DE4025879A1 (enExample)
FI (1) FI921691A0 (enExample)
HU (1) HUT60504A (enExample)
PL (1) PL294368A1 (enExample)
TW (1) TW197448B (enExample)
WO (1) WO1992003463A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007904A1 (en) * 1992-10-01 1994-04-14 Mcneilab, Inc. Derivatives of 7,8-disubstituted guanosines
GB9301000D0 (en) * 1993-01-20 1993-03-10 Glaxo Group Ltd Chemical compounds
CN114437159B (zh) * 2022-04-11 2022-06-28 佛山市晨康生物科技有限公司 一种环状碳酸酯核苷类化合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4167565A (en) * 1976-11-08 1979-09-11 Abbott Laboratories Adenosine-5'-carboxamides and method of use
US4514405A (en) * 1981-09-17 1985-04-30 Merck Patent Gesellschaft Mit Beschrankter Haftung Use of adenosine derivatives as anticonvulsants
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
AU579412B2 (en) * 1984-10-26 1988-11-24 Warner-Lambert Company N` - substituted adenosines

Also Published As

Publication number Publication date
PL294368A1 (en) 1993-06-28
FI921691A7 (fi) 1992-04-15
FI921691A0 (fi) 1992-04-15
HU9201080D0 (en) 1992-06-29
CA2064869A1 (en) 1992-02-17
JPH05502889A (ja) 1993-05-20
CS97892A3 (en) 1992-08-12
HUT60504A (en) 1992-09-28
AU8303291A (en) 1992-03-17
AU638600B2 (en) 1993-07-01
WO1992003463A1 (de) 1992-03-05
TW197448B (enExample) 1993-01-01
EP0496852A1 (de) 1992-08-05

Similar Documents

Publication Publication Date Title
EP0000113B1 (de) Dihydropyridazone, ihre Herstellung und sie enthaltende Arzneimittel sowie Dihydropyridazone zur Verwendung für therapeutische Behandlung
EP0242851A1 (de) N-(2'-Aminophenyl)-benzamid-Derivate, Verfahren zu deren Herstellung und deren Verwendung bei der Bekämpfung neoplastischer Erkrankungen
AT393507B (de) Neue purinylribofuranuronsaeurederivate, verfahren zu deren herstellung und sie enthaltende therapeutische praeparate
DE3005580C2 (enExample)
DE68925270T2 (de) Pyrrolo[3,2-e]pyrazolo[1,5-a]pyrimidinderivate und diese enthaltende Arzneimittel
EP0053767B1 (de) Tricyclische Cytosinderivate zur Verwendung in Arzneimitteln und Verfahren zu ihrer Herstellung
EP0374095A2 (de) Piperidinderivate
EP0161599A2 (de) Neue Benzazepinderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE3940021C2 (de) Adenosin-Derivate, deren Herstellung und Verwendung
DE2523103A1 (de) Neue propargyl-2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
EP0621037A1 (de) Pyrido-pyrimidindione, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0071102B1 (de) Neue Benztriazole, ihre Herstellung und ihre Verwendung als Arzneimittel
EP0519291A1 (de) Aminomethyl-substituierte 2,3-Dihydropyrano(2,3-b)pyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
EP0665228A1 (de) Neue 3-Phenylsulfonyl-3,7-diazabicyclo(3,3,1)nonan-Verbindungen enthaltende Arzneimittel
DE4025879A1 (de) Neue adenosin derivate, deren herstellung und verwendung
DE2632118B2 (de) Apovincaminolester und Verfahren zu deren Herstellung und Arzneimittel
EP0405298A1 (de) Thienopyran-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung
EP0089528B1 (de) 6-Aryl-4,5-dihydro-3(2H)-pyridazinone,ihre Herstellung und Verwendung
DE1915230B2 (de) Hydroxyphenylalkylaminderivate, verfahren zu deren herstellung und arzneimittel auf deren basis
DE2921844C2 (de) 1-(2-Chlorethyl)-1-nitroso-3-substituierte-3-glycosylharnstoffe, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende pharmazeutische Zubereitungen
EP0045911B1 (de) Neue Aminopropanol-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0086453A2 (de) Thiazaspiranderivate, Verfahren zu ihrer Herstellung und Arzneimittel
EP0095641B1 (de) Chinazolinonderivate, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE3120913C2 (enExample)
DE3703633A1 (de) Purin-derivate, ihre herstellung und sie enthaltende arzneimittel

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee